Marshall Wace
HCAR

Marshall Wace’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Marshall Wace’s Portfolio HCAR Stock Details HCAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,283,186
Closed -$12.8M – 3703
2022
Q3 		$12.8M Hold
1,283,186
– – 0.03% 705
2022
Q2 		$12.6M Buy
1,283,186
+15,589
+1% +$153K 0.03% 712
2022
Q1 		$12.4M Buy
1,267,597
+16,205
+1% +$158K 0.02% 730
2021
Q4 		$12.2M Buy
1,251,392
+1,039,494
+491% +$10.2M 0.02% 729
2021
Q3 		$2.06M Buy
+211,898
New +$2.05M 0.01% 1521

Marshall Wace's HCAR Position: Q4 2022 in Review

Marshall Wace sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 1,283,186 shares — an estimated $12.8M sold.

Marshall Wace first reported a position in HCAR in Q3 2021 and held it in 5 quarters. The position peaked at $12.8M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • Marshall Wace reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 1,283,186 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $12.8M.
  • Marshall Wace first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q3 2021 and held it in 5 quarters.
  • Marshall Wace's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $12.8M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.